Enhabit Cash on Hand 2020-2024 | EHAB
Enhabit cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Enhabit Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $30 |
| 2023 | $30 |
| 2022 | $27 |
| 2021 | $8 |
| 2020 | $40 |
| 2019 | $0 |
| Enhabit Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $30 |
| 2024-09-30 | $47 |
| 2024-06-30 | $30 |
| 2024-03-31 | $39 |
| 2023-12-31 | $30 |
| 2023-09-30 | $35 |
| 2023-06-30 | $37 |
| 2023-03-31 | $40 |
| 2022-12-31 | $27 |
| 2022-09-30 | $48 |
| 2022-06-30 | $54 |
| 2022-03-31 | $21 |
| 2021-12-31 | $8 |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | $40 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.536B | $1.035B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.417B | 25.21 |
| Elevance Health (ELV) | United States | $84.565B | 10.91 |
| CVS Health (CVS) | United States | $75.952B | 9.44 |
| Cencora (COR) | United States | $54.132B | 18.82 |
| DiDi Global (DIDIY) | China | $21.231B | 32.22 |
| Natera (NTRA) | United States | $20.665B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.308B | 13.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Doximity (DOCS) | United States | $11.108B | 57.77 |
| CochLear (CHEOY) | Australia | $11.097B | 0.00 |
| Revvity (RVTY) | United States | $10.729B | 18.46 |
| ICON (ICLR) | Ireland | $10.678B | 9.93 |
| Viatris (VTRS) | United States | $9.882B | 3.40 |
| Avantor (AVTR) | United States | $8.756B | 12.72 |
| HealthEquity (HQY) | United States | $8.482B | 41.73 |
| Medpace Holdings (MEDP) | United States | $8.385B | 22.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.090B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.825B | 13.37 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.093B | 37.89 |
| Bausch + Lomb (BLCO) | Canada | $4.082B | 24.06 |
| Sotera Health (SHC) | United States | $3.636B | 20.66 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.918B | 37.95 |
| Concentras Parent (CON) | United States | $2.739B | 15.83 |
| Organon (OGN) | United States | $2.090B | 2.22 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| Premier (PINC) | United States | $2.056B | 14.07 |
| Progyny (PGNY) | United States | $1.874B | 41.24 |
| GeneDx Holdings (WGS) | United States | $1.696B | 65.33 |
| PACS (PACS) | United States | $1.666B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.638B | 30.50 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 9.27 |
| Agilon Health (AGL) | United States | $1.105B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.054B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.892B | 13.93 |
| Nutex Health (NUTX) | United States | $0.884B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| Embecta (EMBC) | United States | $0.677B | 4.56 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Sonida Senior Living (SNDA) | United States | $0.496B | 0.00 |
| LifeMD (LFMD) | United States | $0.434B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.358B | 0.00 |
| SBC Medicals (SBC) | United States | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.203B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| Oncology Institute (TOI) | United States | $0.179B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.074B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| KindlyMD (KDLY) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| Biodesix (BDSX) | United States | $0.032B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |